Analyst Profile – Charmaine Chan

Tag: healthcare

Coronavirus - The Mutated Strain (Q&A)

In our third Q&A segment on COVID-19, Cambiar Senior Analyst Charmaine Chan provides insights into the mutated version of the virus and the efficacy of vaccines.

SMID & Small Cap Value - 2Q20 Review

Cambiar SMID and Small Cap Value portfolio managers provide an update on their portfolios and discuss outperformance for the quarter.

Coronavirus - What You Need to Know Part II

Cambiar Senior Analyst Charmaine Chan provides her second Q&A segment on COVID-19.  She details the latest on possible vaccines, the next steps for the U.S. on the road to recovery, and the likeliness of a second wave of coronavirus.

SMID & Small Cap Value - 1Q20 Review

Cambiar SMID and Small Cap Value portfolio managers provide an update on their portfolios during the current bear market.

Global Virus Crisis - April 2020 Update

Cambiar President Brian Barish provides his latest thoughts on the Global Virus Crisis, the current event-driven bear market, and the categories of investment opportunities.

SMID & Small Cap Value Updates

Cambiar SMID and Small Cap Value portfolio managers provide an update on their portfolios during the current bear market.